Emerging respiratory viral infections: MERS-CoV and influenza [PDF]
This article is made available for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source.
Al-Tawfiq, Jaffar A., Memish, Ziad A.
core +1 more source
Consensus definitions of 14 severe acute toxic effects for childhood lymphoblastic leukaemia treatment: a Delphi consensus [PDF]
Although there are high survival rates for children with acute lymphoblastic leukaemia, their outcome is often counterbalanced by the burden of toxic effects.
Attarbaschi, Andishe +20 more
core +2 more sources
Background/purpose: Pulmonary veno-occlusive disease (PVOD) is a rare but fatal cause of pulmonary hypertension reported to be linked to mutations of eukaryotic initiation factor 2 alpha kinase 4 (EIF2AK4), also known as general control nonderepressible ...
Ying-Ju Lai +3 more
doaj +1 more source
Acute pulmonary hypertension caused by tumor embolism: a report of two cases. [PDF]
Acute pulmonary hypertension leading to right ventricular failure and circulatory collapse is usually caused by thromboembolic obstruction of the pulmonary circulation.
Liaudet, L. +4 more
core +1 more source
Co-existence of vocal cord dysfunction with pulmonary conditions other than asthma: A case series
Background: Vocal cord dysfunction (VCD) is defined as inappropriate movement of the vocal cords resulting in functional airway obstruction and symptoms including cough, wheezing, and dyspnea.
Merritt L. Fajt +3 more
doaj +1 more source
Targeting Vascular Remodeling to Treat Pulmonary Arterial Hypertension [PDF]
Pulmonary arterial hypertension (PAH) describes a group of conditions with a common hemodynamic phenotype of increased pulmonary artery pressure, driven by progressive remodeling of small pulmonary arteries, leading to right heart failure and death ...
Lawrie, A., Thompson, A.A.R.
core +1 more source
Clinical features of canine pulmonary veno‐occlusive disease and pulmonary capillary hemangiomatosis
Background Histologic features of pulmonary veno‐occlusive disease (PVOD) and pulmonary capillary hemangiomatosis (PCH) have been described in dogs but without a thorough clinical description.
Carol R. Reinero +5 more
doaj +1 more source
Familial Pulmonary Capillary Hemangiomatosis Early in Life [PDF]
Background: Pulmonary capillary hemangiomatosis (PCH) is a rare disease, especially in infancy. Four infants have been reported up to the age of 12 months. So far, no familial patients are observed at this age.
Hebestreit, Helge +4 more
core +1 more source
The Endothelial CXCR Family in Vascular Health and Disease
ABSTRACT Endothelial cells (ECs) form the dynamic interface between blood and tissue, serving as key regulators of vascular homeostasis, inflammation, and repair. Among the molecular systems governing endothelial behavior, the C‐X‐C motif chemokine receptor (CXCR) family—originally characterized in immunology for its roles in leukocyte trafficking and ...
Zhiming Wu +4 more
wiley +1 more source
Pulmonary Veno-Occlusive Disease: A Rare Cause of Pulmonary Hypertension
Pulmonary veno-occlusive disease (PVOD) is a rare entity that is usually mistaken with pulmonary arterial hypertension (PAH) but is considered class I′ of PAH. It is important to subclassify PVOD and distinguish it from PAH as treatment with vasodilators
Said Hajouli MD +2 more
doaj +1 more source

